Skip to main content
Premium Trial:

Request an Annual Quote

Scienion Adds Czech Firm BioVendor to Growing List of Immunoassay Manufacturing Clients

Premium

German array company Scienion recently announced that BioVendor, a provider of medical equipment and research products, is using Scienion's instruments to develop and manufacture in vitro diagnostic and research-use immunoassays, as well as antibodies and recombinant proteins.

CEO Holger Eickhoff told BioArray News this week that BioVendor, based in Brno, Czech Republic, is the latest Scienion customer to announce its adoption of the German firm's tools for manufacturing immunoassays. Other companies that have publicly discussed their relationship with Scienion include Toronto-based SQI Diagnostics, Maine Manufacturing, and Genalyte, he said.

According to Eickhoff, BioVendor is using a number of Scienion products in its manufacturing process, including its SciFlexarrayer dispensers, SciPlex microtiter plates, and SciReader CL for detection of assay results, according to Scienion.

He said that BioVendor's SciFlexarrayers are configured with the Berlin-based company's SciDrop Pico and Nano capabilities. Pico delivers between 50 and 800 picoliters per droplet, while Nano enables the delivery of between eight and 200 nanoliters per droplet, he said. Both offer Scienion customers "an increased range in liquid handling and feature sizes of spots and lines," Eickhoff noted.

BioVendor CEO Viktor Růžička said in a statement that the company is using Scienion's tools to develop new multiplex tests in microtiter plates. Among the IVDs in development is a test for Borrelia infections.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.